Join
Live feed
·
INSIDERFilingvia Quantisnow
Neos Therapeutics, Inc. logo

SEC Form 4: M John Limongelli disposed of $14,335 worth of Common Stock (16,985 units at $0.84), decreasing direct ownership by 17% to 83,015 units

ByQuantisnow·Wall Street's wire, on your screen.
NEOS· Neos Therapeutics, Inc.
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track NEOS (Neos Therapeutics, Inc.) and more on Quantisnow.